In Vitro Exposure Systems and Dosimetry Assessment Tools for Inhaled Tobacco Products: Workshop Proceedings, Conclusions and Paths Forward for In Vitro Model Use

Autor: Hans Raabe, Kent E. Pinkerton, Suzanne Fitzpatrick, Rodger Curren, Bahman Asgharian, Sonia Grego, Jason Adamson, Holger Behrsing, Chris J. Wright, Irfan Rahman, Erin Hill, Michaela Aufderheide, Richard A. Corley, Michael J. Oldham, Sandro Steiner, Shaun D. McCullough, Günter Oberdörster, Roman Wieczorek, Xiang Li, Tobias Krebs, Robert B. Devlin, Pei-Hsuan Chu, Raymond R. Tice
Rok vydání: 2017
Předmět:
0301 basic medicine
Smoking prevention
e-cigarette exposure systems
Electronic Nicotine Delivery Systems
tobacco exposure systems
010501 environmental sciences
Toxicology
01 natural sciences
Tobacco smoke
In vitro model
Regulatory authority
2.2 Factors relating to the physical environment
Medicine
Aetiology
Lung
Cancer
in vitro models
reconstructed epithelium airway models
dosimetry
Smoking
Tobacco control
in vitro
Tobacco Products
General Medicine
Medical Laboratory Technology
pulmonary models
Respiratory
in vitro lung
Tobacco product
medicine.medical_specialty
In Vitro Techniques
computational fluid dynamics
Article
General Biochemistry
Genetics and Molecular Biology

tobacco regulatory science
03 medical and health sciences
Species Specificity
Toxicity Tests
Tobacco
Animals
Humans
COPD
Medical physics
Veterinary Sciences
0105 earth and related environmental sciences
Aerosols
Tobacco Smoke and Health
United States Food and Drug Administration
business.industry
Prevention
ex vivo lung models
In vitro exposure
United States
Good Health and Well Being
030104 developmental biology
non-animal alternatives
business
Zdroj: Alternatives to laboratory animals : ATLA, vol 45, iss 3
Altern Lab Anim
Scopus-Elsevier
ISSN: 2632-3559
0261-1929
Popis: In 2009, the passing of the Family Smoking Prevention and Tobacco Control Act facilitated the establishment of the FDA Center for Tobacco Products (CTP), and gave it regulatory authority over the marketing, manufacture and distribution of tobacco products, including those termed ‘modified risk’. On 4–6 April 2016, the Institute for In Vitro Sciences, Inc. (IIVS) convened a workshop conference entitled, In Vitro Exposure Systems and Dosimetry Assessment Tools for Inhaled Tobacco Products, to bring together stakeholders representing regulatory agencies, academia and industry to address the research priorities articulated by the FDA CTP. Specific topics were covered to assess the status of current in vitro smoke and aerosol/vapour exposure systems, as well as the various approaches and challenges to quantifying the complex exposures in in vitro pulmonary models developed for evaluating adverse pulmonary events resulting from tobacco product exposures. The four core topics covered were: a) Tobacco Smoke and E-Cigarette Aerosols; b) Air–Liquid Interface- In Vitro Exposure Systems; c) Dosimetry Approaches for Particles and Vapours/ In Vitro Dosimetry Determinations; and d) Exposure Microenvironment/Physiology of Cells. The 2.5-day workshop included presentations from 20 expert speakers, poster sessions, networking discussions, and breakout sessions which identified key findings and provided recommendations to advance these technologies. Here, we will report on the proceedings, recommendations, and outcome of the April 2016 technical workshop, including paths forward for developing and validating non-animal test methods for tobacco product smoke and next generation tobacco product aerosol/vapour exposures. With the recent FDA publication of the final deeming rule for the governance of tobacco products, there is an unprecedented necessity to evaluate a very large number of tobacco-based products and ingredients. The questionable relevance, high cost, and ethical considerations for the use of in vivo testing methods highlight the necessity of robust in vitro approaches to elucidate tobacco-based exposures and how they may lead to pulmonary diseases that contribute to lung exposure-induced mortality worldwide.
Databáze: OpenAIRE